In response to recent meningitis B outbreaks, health authorities are considering providing a vaccine to 15-year-olds. This initiative follows a tragic incident in Kent where two teenagers lost their lives earlier this year.
The Joint Committee on Vaccination and Immunisation (JCVI) is recommending an expanded vaccination program after a successful one-time vaccination campaign among university students. The government will now review this proposal.
Prof Wei Shen Lim, JCVI chair, emphasized the severity of invasive meningococcal disease and its potential life-altering consequences. The committee collaborated with meningitis charities and valued input from individuals affected by the disease.
Meningococcal B, a serious infection, can lead to life-threatening conditions such as brain inflammation and sepsis, resulting in disabilities like amputations, hearing loss, and brain damage. The disease spreads through close contact with an infected person, including activities like sharing drinks or living in close quarters.
The tragic death of Juliette Kenny in the Kent outbreak has spurred calls for routine menB vaccination for young people. Recent outbreaks have highlighted the urgent need for a comprehensive vaccination strategy to prevent further tragedies.
Currently, one million young individuals in England are eligible for a two-dose MenB vaccine program. Eligible individuals, including 17 and 18-year-olds and students under 25 heading to college or university, are encouraged to schedule their vaccinations at local pharmacies for optimal protection.
Prof Shen Lim emphasized the importance of completing the two-dose vaccine regimen before starting college or university. The second dose should be administered at least 28 days after the first to ensure full protection against meningitis B.
